Free Trial
NASDAQ:ELOX

Eloxx Pharmaceuticals (ELOX) Stock Price, News & Analysis

Eloxx Pharmaceuticals logo
$0.0002
0.00 (0.00%)
(As of 11/1/2024 ET)

About Eloxx Pharmaceuticals Stock (NASDAQ:ELOX)

Key Stats

Today's Range
$0.0002
$0.0002
50-Day Range
$0.00
$0.84
52-Week Range
$0.00
$1.90
Volume
5,892 shs
Average Volume
12,256 shs
Market Capitalization
$628.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company also develops various preclinical programs for the treatment of alport syndrome, recessive dystrophic epidermolysis bullosa, junctional epidermolysis bullosa, and familial adenomatous polyposis, as well as various earlier discovery stage programs in oncology. Eloxx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Watertown, Massachusetts.

Receive ELOX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eloxx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ELOX Stock News Headlines

Tim Sykes’ Urgent Trade Alert: “Make this move now”
Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.
Eloxx Pharmaceuticals Inc (ELOX)
See More Headlines

ELOX Stock Analysis - Frequently Asked Questions

Eloxx Pharmaceuticals' stock was trading at $1.20 at the beginning of the year. Since then, ELOX stock has decreased by 100.0% and is now trading at $0.0002.
View the best growth stocks for 2024 here
.

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) posted its quarterly earnings results on Monday, April, 3rd. The company reported ($2.92) earnings per share for the quarter, topping the consensus estimate of ($2.97) by $0.05.

Shares of ELOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Eloxx Pharmaceuticals investors own include Tesla (TSLA), ADMA Biologics (ADMA), Adverum Biotechnologies (ADVM), Assertio (ASRT), Fulcrum Therapeutics (FULC), Acasti Pharma (ACST) and Akebia Therapeutics (AKBA).

Company Calendar

Last Earnings
4/03/2023
Today
11/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:ELOX
Employees
18
Year Founded
2013

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($4.92) per share

Miscellaneous

Free Float
2,508,000
Market Cap
$628.00
Optionable
Not Optionable
Beta
2.63
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for November 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

This page (NASDAQ:ELOX) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners